- Home
- JAGX vs PALI Comparison
JAGX vs PALI Comparison
Compare JAGX & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- PALI
- Stock Information
- Founded
- JAGX 2013
- PALI 1996
- Country
- JAGX United States
- PALI United States
- Employees
- JAGX N/A
- PALI N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JAGX Health Care
- PALI Health Care
- Exchange
- JAGX Nasdaq
- PALI Nasdaq
- Market Cap
- JAGX 3.8M
- PALI 3.2M
- IPO Year
- JAGX N/A
- PALI N/A
- Fundamental
- Price
- JAGX $8.06
- PALI $0.74
- Analyst Decision
- JAGX
- PALI Strong Buy
- Analyst Count
- JAGX 0
- PALI 2
- Target Price
- JAGX N/A
- PALI $23.00
- AVG Volume (30 Days)
- JAGX 66.3K
- PALI 47.7K
- Earning Date
- JAGX 05-13-2025
- PALI 05-12-2025
- Dividend Yield
- JAGX N/A
- PALI N/A
- EPS Growth
- JAGX N/A
- PALI N/A
- EPS
- JAGX N/A
- PALI N/A
- Revenue
- JAGX $11,689,000.00
- PALI N/A
- Revenue This Year
- JAGX $38.22
- PALI N/A
- Revenue Next Year
- JAGX $39.96
- PALI N/A
- P/E Ratio
- JAGX N/A
- PALI N/A
- Revenue Growth
- JAGX 19.75
- PALI N/A
- 52 Week Low
- JAGX $4.02
- PALI $0.60
- 52 Week High
- JAGX $540.00
- PALI $9.09
- Technical
- Relative Strength Index (RSI)
- JAGX 57.58
- PALI 48.58
- Support Level
- JAGX $5.00
- PALI $0.67
- Resistance Level
- JAGX $6.13
- PALI $0.77
- Average True Range (ATR)
- JAGX 0.87
- PALI 0.05
- MACD
- JAGX 0.72
- PALI 0.02
- Stochastic Oscillator
- JAGX 88.07
- PALI 79.71
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.